18 results with keyword: 'oral immunotherapy food allergy new horizon'
A DBPCFC was done at the end of the OIT protocol and showed a signifi- cant increase in the tolerated doses of egg protein compared to the rush phase and an increase in the
N/A
OIT, oral immunotherapy; SLIT, sublingual immunotherapy; EPIT, epicutaneous immunotherapy; SCIT, subcutaneous immunotherapy; CM, cow's milk; OFC, oral food challenge; FAHF, food
N/A
FA: Food allergy; OIT: Oral immunotherapy; mOIT: Oral immunotherapy with multiple food allergens simultaneously; HRQL: Health-related quality of life; FAQL-PB: Food allergy quality
N/A
Fleischer DM, Burks AW, Vickery BP, Scurlock AM, Wood RA, Jones SM, Sicherer SH, Liu AH, Stablein D, Henning AK, Mayer L, Lindblad R, Plaut M, Sampson HA, Consortium of Food Allergy
N/A
AIT: antigen-specific immunotherapy; CMA: cow’s milk allergy; PNA: peanut allergy; OIT: oral immunotherapy; SCIT: subcutaneous immunotherapy; FoxP3: forkhead box protein 3;
N/A
The purpose of these treatments is to enable patients of food al- lergy to ingest offending foods to some extent with- out obvious adverse reactions, and I myself call our own
N/A
By using data collected by the JULIA radar, along with TEC and GPS scintillations, we have constructed a very com- plete diagnostic of the background and the turbulent state of
N/A
Earth Planets Space, 61, 411?430, 2009 The spread F Experiment (SpreadFEx) Program overview and first results D C Fritts1, M A Abdu2, B R Batista2, I S Batista2, P P Batista2, R Buriti3, B
N/A
Zaradi ome- jenega prostora na streˇ zniku, so vsi video posnetki shranjeni na strani Yo- utube, v bazi naˇsega portala pa kot URL video posnetka strani Youtube. Prav tako
N/A
osobu koju on odredi jest zatvorenikovo puštanje na slobodu, ali samo ako tijekom pregleda ili povodom pritužbe zatvorenika utvrdi da je istekao rok trajanja istražnog
N/A
Dose progression was measured as time to reach 10-fold in- crease from initial cumulative dose eliciting a reaction on DBPCFC to peanut as well as doses of 300, 1000 and 4000 mg
N/A
AIT: Allergen immunotherapy; CCD: Cross-reactive carbohydrate determinants; CEFA: Cofactor-enhanced food allergy; CRD: Component resolved diagnosis; MA: Molecular allergy;
N/A
This Guideline, prepared by the European Academy of Allergy and Clinical Immunology (EAACI) Task Force on Allergen Immunotherapy for IgE-mediated Food Allergy,
N/A
NFS and/or CIFS exports (GEO/UZH) – Export stored data to researchers personal PCs – Allows prepare input data for data processing and – Data accessible by the
N/A
Health economic analysis of allergen immunotherapy for the manage‑ ment of allergic rhinitis, asthma, food allergy and venom allergy: a systematic overview. Timmins N, Rawlins
N/A
Health Economic Analysis of Allergen Immunotherapy (AIT) for the Management of Allergic Rhinitis, Asthma, Food Allergy and Venom Allergy: A Systematic Overview.. 1 Miqdad Asaria,
N/A